CARPAGNANO, GIOVANNA ELISIANA
 Distribuzione geografica
Continente #
NA - Nord America 5.173
EU - Europa 1.710
AS - Asia 836
SA - Sud America 172
AF - Africa 7
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.901
Nazione #
US - Stati Uniti d'America 5.149
RU - Federazione Russa 444
SE - Svezia 423
SG - Singapore 414
CN - Cina 271
IT - Italia 231
DE - Germania 172
BR - Brasile 156
GB - Regno Unito 101
FI - Finlandia 80
FR - Francia 75
UA - Ucraina 63
ID - Indonesia 37
VN - Vietnam 31
HK - Hong Kong 27
CZ - Repubblica Ceca 25
IN - India 24
NL - Olanda 23
CA - Canada 21
IE - Irlanda 20
AT - Austria 16
BE - Belgio 16
LT - Lituania 13
UZ - Uzbekistan 5
AR - Argentina 4
CO - Colombia 4
EC - Ecuador 3
ES - Italia 3
IQ - Iraq 3
PY - Paraguay 3
TR - Turchia 3
AU - Australia 2
DK - Danimarca 2
KG - Kirghizistan 2
MA - Marocco 2
PK - Pakistan 2
PL - Polonia 2
TH - Thailandia 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CG - Congo 1
EG - Egitto 1
EU - Europa 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
KE - Kenya 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MX - Messico 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
RO - Romania 1
SA - Arabia Saudita 1
TJ - Tagikistan 1
TW - Taiwan 1
VE - Venezuela 1
Totale 7.901
Città #
Fairfield 787
Chandler 534
Woodbridge 439
Ashburn 425
Nyköping 354
Seattle 328
Houston 296
Cambridge 287
Singapore 261
Wilmington 253
Jacksonville 142
Lawrence 142
Roxbury 126
Ann Arbor 120
Des Moines 92
New York 83
Inglewood 62
San Diego 58
Helsinki 49
Munich 45
London 42
Los Angeles 41
Bari 40
Paris 40
Jakarta 37
Dearborn 36
Nanjing 35
Princeton 32
Santa Clara 31
Boardman 29
Dong Ket 29
Beijing 27
Hong Kong 27
Rome 24
Frankfurt am Main 21
Nuremberg 20
Brooklyn 19
Dublin 17
Brussels 16
Milan 15
Falkenstein 14
Olomouc 14
Moscow 13
Hebei 12
São Paulo 12
Brno 11
Guangzhou 11
Norwalk 11
Shanghai 11
Shenyang 11
Washington 11
Pune 10
Toronto 10
Turi 10
Tianjin 8
Chicago 7
Ottawa 7
Siena 7
Auburn Hills 6
Changsha 6
Hounslow 6
Jiaxing 6
Leipzig 6
Taranto 6
Vienna 6
Wuhan 6
Belo Horizonte 5
Grottaglie 5
Hyderabad 5
Kilburn 5
Lauterbourg 5
Reggio Calabria 5
Xi'an 5
Zibo 5
Chiswick 4
Düsseldorf 4
Falls Church 4
Fortaleza 4
Kunming 4
Palermo 4
Redwood City 4
Strasbourg 4
Tashkent 4
Zhengzhou 4
Amsterdam 3
Beauharnois 3
Brasília 3
Buffalo 3
Chengdu 3
Goiânia 3
Hefei 3
Jinan 3
Modugno 3
Nanchang 3
Pescara 3
Portsmouth 3
Prescot 3
Sorocaba 3
Sterling 3
Tolentino 3
Totale 5.827
Nome #
Application of machine learning to predict obstructive sleep apnea syndrome severity 144
A survey of fungal microbiota in airways of healthy volunteer subjects from Puglia (Apulia), Italy 124
Oxygen therapy at low flow causes oxidative stress in chronic obstructive pulmonary disease: Prevention by N-acetyl cysteine 121
Airway inflammation in subjects with gastro-oesophageal reflux and gastro-oesophageal reflux-related asthma 120
"Malattie dell’apparato respiratorio. Pneumologia e chirurgia toracica" 111
Assessment of Induced Sputum Cellularity in COPD Patients Belonging to Two Different Classes of Air Pollution Exposure 109
Interleukin-6 is increased in breath condensate of patients with non-small cell lung cancer. 106
Gender difference in sleep profile of severely obese patients with obstructive sleep apnea (OSA) 105
3p microsatellite alterations in exhaled breath condensate from patients with non-small cell lung cancer 101
Exhaled Interleukine-6 and 8-isoprostane in chronic obstructive pulmonary disease: effect of carbocysteine lysine salt monohydrate (SCMC-Lys) 96
Changes in sputum composition during 15 min of sputum induction in healthy subjects and patients with asthma and chronic obstructive pulmonary disease 94
8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy 93
Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients 91
Gender, age and menopause effects on the prevalence and the characteristics of obstructive sleep apnea in obesity. 88
Supplementary oxygen in healthy subjects and those with COPD increases oxidative stress and airway inflammation 88
Exhaled inflammatory markers in aspirin-induced asthma syndrome. 87
Increased IL-6 and IL-4 in exhaled breath condensate of patients with nasal polyposis 86
Predictive equations for CPAP titration in OSAS patients 83
Menopausal asthma: a new biological phenotype? 81
Influence of subclinical hypothyroidism and T4 treatment on the prevalence and severity of obstructive sleep apnoea syndrome (OSAS) 81
Physical activity as a new tool to evaluate the response to omalizumab and mepolizumab in severe asthmatic patients: A pilot study 80
Validity and reproducibility of morphologic analysis of nasal secretions obtained using ultrasonic nebulization of hypertonic solution. 76
The role of obstructive sleep apnea syndrome and obesity in determining leptin in the exhaled breath condensate 74
Could neutrophilic airway inflammation in obese people be more due to obstructive sleep apnoea syndrome than to asthma? 72
Severe uncontrolled asthma with bronchiectasis: A pilot study of an emerging phenotype that responds to mepolizumab 70
Exhaled markers in the monitoring of airways inflammation and its response to steroid's treatment in mild persistent asthma 67
Airway inflammation in patients affected by obstructive sleep apnea syndrome 66
The importance of maintaining the same order of performance of lung function and SNIP tests in patients with amyotrophic lateral sclerosis 66
Aging and airway inflammation 65
Exhaled Volatile Organic Compounds analysis by e-nose can detect Idiopathic Pulmonary Fibrosis 65
A European respiratory society technical standard: Exhaled biomarkers in lung disease 64
Role of plasmatic leptin in response to hypercapnia in obese patients with or without osas 63
3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer 63
Body mass index, airflow obstruction, dyspnea, and exercise index is not modified after 6 months therapy with roflumilast in a cohort of patients with chronic obstructive pulmonary disease 63
Use of exhaled breath condensate in the study of airway inflammation after hypertonic saline solution challenge 62
Fractional Exhaled Nitric Oxide (FENO) in the management of asthma: a position paper of the Italian Respiratory Society (SIP/IRS) and Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC) 62
Switching from omalizumab to mepolizumab: real-life experience from Southern Italy 62
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes 61
Exhaled Nitric Oxide and Exhaled Breath Temperature as Potential Biomarkers in Patients with Pulmonary Hypertension 60
Prevalence of comorbidities in patients with obstructive sleep apnea syndrome, overlap syndrome and obesity hypoventilation syndrome 59
Is the Exhaled Breath Temperature Sensitive to Cigarette Smoking? 59
Omalizumab as add-on therapy in a patient with severe asthma and OSA 58
Analysis of the fungal microbiome in exhaled breath condensate of patients with asthma 58
Evaluation of adiponectin profile in Italian patients affected by obstructive sleep apnea syndrome 57
COVID-19 as a Paradigmatic Model of the Heterogeneous Disease Presentation in Older People: Data from the GeroCovid Observational Study 56
Analysis of mitochondrial DNA alteration in new phenotype ACOS 56
Bamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infection 56
Exhaled Breath Condensate (EBC) for SARS-CoV-2 diagnosis still an open debate 55
The association between dysphagia and OSA Disfagia e OSA 55
Use of the exhaled breath condensate in the study of airway inflammation after hypertonic saline challenge 54
Systemic and airways inflammation in healthy subjects of different ages 53
Diurnal PaCO2 tension in obese women: relationship with sleep disordered breathing 53
Association between exhaled nitric oxide and nasal polyposis in severe asthma 53
Endothelial dysfunction assessment by noninvasive peripheral arterial tonometry in patients with chronic obstructive pulmonary disease compared with healthy subjects 53
Microparticles in sputum of COPD patients: a potential biomarker of the disease? 53
IL-2, TNF-alpha, and leptin: local versus systemic concentrations in NSCLC patients 52
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) 52
Exhaled condensate of endothelin-1 and exhaled nitric oxide are increased in COPD patients with secondary pulmonary hypertension 49
The potential role of endothelial dysfunction and platelet activation in the development of thrombotic risk in COPD patients 49
Evidence of lower oxidative stress in the air spaces of patients with reversible COPD 49
MicroRNA expression profile during different conditions of hypoxia 49
Mucopenetration study of solid lipid nanoparticles containing magneto sensitive iron oxide 49
Aspergillus spp. colonization in exhaled breath condensate of lung cancer patients from Puglia Region of Italy 48
Study of mitochondrial DNA alteration in the exhaled breath condensate of patients affected by obstructive lung diseases 48
Transthoracic ultrasound sign in severe asthmatic patients: a lack of "gliding sign" mimic pneumothorax 47
Characterization of obstructive sleep apnea–hypopnea syndrome (OSA) population by means of cluster analysis 46
Is the exhaled breath temperature in lung cancer influenced by airways neoangiogenesis or by inflammation? 46
Treatment response according to small airways disease status: The effects of high-strength extrafine pMDI beclomethasone dipropionate/formoterol fumarate in fixed dose combination in moderate uncontrolled asthmatic patients 46
Relationship Between Oral Lesions and Severe SARS-CoV-2 Infection in Intensive Care Unit Patients 45
Airway cell patterns in patients suffering from COPD and OSAS (Overlap Syndrome) 45
Exhaled breath temperature in NSCLC: Could be a new non-invasive marker? 45
How strong is the association between IPF and lung cancer? An answer from airway’s DNA 45
Breathing rhythm variations during wash-in do not influence exhaled volatile organic compound profile analyzed by an electronic nose 45
Nailfold capillaroscopic findings in systemic sclerosis related lung fibrosis and in idiopathic lung fibrosis 44
Dyspnea perception in asthma: Role of airways inflammation, age and emotional status 44
Values in Elderly People for Exhaled Nitric Oxide Study 44
Systemic and airways inflammation in healthy subjects and COPD patients of different ages 43
VIP: A New Promising Marker for AECOPD-A Fashionable Marker Soon Forgotten? 43
Prognostic value of Exhaled Microsatellite alterations at 3p in NSCLC patients 43
A New SERPINA-1 Missense Mutation Associated with Alpha-1 Antitrypsin Deficiency and Bronchiectasis 43
Could exhaled ferritin and SOD be used as markers for lung cancer and prognosis prediction purposes? 43
Exhaled matrix metalloproteinase-9 in lung cancer 43
Mitochondrial DNA alteration in obstructive sleep apnea 43
Viral colonization in exhaled breath condensate of lung cancer patients: Possible role of EBV and CMV 43
Wake-up call by breathomics in sleep apnoea 43
Coexistent Sarcoidosis and Tuberculosis: A Case Report 43
Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19 43
Airways oxidative stress, lung function and cognitive impairment in aging 42
The Role of Airways 17β-Estradiol as a Biomarker of Severity in Postmenopausal Asthma: A Pilot Study 42
HPV in exhaled breath condensate of lung cancer patients 41
HPV-associated lung cancers: An international pooled analysis 41
Cigarette smoke and increased COX-2 and survivin levels in exhaled breath condensate of lung cancer patients: How hot is the link? 41
Effects of omalizumab in severe asthmatics across ages: A real life Italian experience 41
Incidence of deep venous thrombosis in patients with both pulmonary embolism and copd 41
Validation of the Exhaled Breath Temperature Measure: Reference Values in Healthy Subjects 40
Asymmetric dimethylarginine (ADMA): will be or will not be a new revolutionary biomarker of bronchial asthma? 40
Searching for Inflammatory and Oxidative Stress Markers Capable of Clustering Severe Asthma 40
Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub-phenotypes of response identified by cluster analysis 40
Home mechanical ventilation (HMV) decreases mortality in patients affected by amyotrophic lateral sclerosis (ALS 39
Exhaled ERCC-1 and ERCC-2 microsatellite alterations in NSCLC patients 39
Totale 6.145
Categoria #
all - tutte 58.762
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.762


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020318 0 0 0 0 0 0 0 0 0 0 256 62
2020/20211.662 206 41 223 72 139 26 345 113 166 110 155 66
2021/2022947 58 43 3 23 41 115 50 49 110 53 185 217
2022/20231.477 189 211 96 86 145 218 41 153 246 11 49 32
2023/2024708 45 125 52 55 93 172 23 25 17 19 9 73
2024/20251.995 117 59 198 115 110 369 320 340 133 203 31 0
Totale 8.383